[Personalized molecular medicine: new paradigms in the treatment of cochlear implant and cancer patients].

about

[Personalized molecular medicine: new paradigms in the treatment of cochlear implant and cancer patients].

Item

http://www.wikidata.org/entity/Q50354999

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

[Personalized molecular medici ...... implant and cancer patients].

@en

[Personalized molecular medici ...... implant and cancer patients].

@nl

type

Item

label

[Personalized molecular medici ...... implant and cancer patients].

@en

[Personalized molecular medici ...... implant and cancer patients].

@nl

prefLabel

[Personalized molecular medici ...... implant and cancer patients].

@en

[Personalized molecular medici ...... implant and cancer patients].

@nl

P1476

[Personalized molecular medici ...... r implant and cancer patients]

@en

P2093

H P Zenner

http://www.w3.org/2001/XMLSchema#string

M Pfister

http://www.w3.org/2001/XMLSchema#string

M Röcken

http://www.w3.org/2001/XMLSchema#string

N Friese

http://www.w3.org/2001/XMLSchema#string

P2860

Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.

Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Current understanding of usher syndrome type II.

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.

P2888

s00106-014-2859-8

P304

520-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00106-014-2859-8

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eberhart Zrenner

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24920503

http://www.w3.org/2001/XMLSchema#string